EN DE
Watch Xunfei Healthcare Tech Co Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Xunfei Healthcare Tech Co Ltd (2506) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Xunfei Healthcare Tech Co Ltd stock HK$52.27, price HK$65.25, that is 19.9% below the price, quality 39 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · Based in China

XH Xunfei Healthcare Tech Co Ltd logo Thin data Nov 16, 2026

Xunfei Healthcare Tech Co Ltd

2506 · HK

Expensive (fair value 20% below the price), weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Low debt 
Revenue last quarter +49% vs. a year ago. 
Expensive Growth (revenue 3y +24.7 %/yr in CNY) 
Fair value HK$52.27 · Overvalued 
Quality 39/100 
Falling price (downtrend) 
Loss-making · -4.7% net margin (TTM) 
Negative free cash flow 
Trails peers (1/10) 
Narrow moat 11/100 · thin data
Thin data 
Estimate⚠ Small free float
Watch Xunfei Healthcare Tech Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$167.00 HK$62.75 Fair Value HK$52.27 Dec 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

23‑month range HK$62.75 – HK$167.00 · fair‑value band HK$39.21 – HK$65.34 · the HK$65.25 price screens above the HK$52.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Xunfei Healthcare Tech Co in your weekly email

Every Wednesday you see whether Xunfei Healthcare Tech Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Xunfei Healthcare Technology Co., Ltd. provides healthcare AI solutions in the People's Republic of China.

Show moreShow less

The company offers primary solutions, including a general practice clinical decision support system (CDSS) and chronic disease management, which enables identification of key populations, one-click chronic disease screening and risk stratification, dynamic health monitoring, smart task reminders, and decision support during service delivery.

It also offers smart hospital solutions, including smart service, smart healthcare, smart medical treatment combination, as well as the iFlytek Xiaoyi APP, an AI health assistant. In addition, the company provides regional public health solutions and medical insurance administrative solutions.

Further, the company provides the Xunfei Xiaoyi APP, an AI-driven post-discharge patient management system, and the Cloud Medical Imaging Platform, which offers remote consultation services; and digital imaging services.

Additionally, it offers intelligent healthcare solutions, including a general practitioner assistant, grass-roots integrated intelligent information platform, family physician assistant, AI chronic disease management system, and a smart surveillance and early warning platform for infectious diseases.

The company's intelligent hardware offerings include smart hearing aids and a smart sphygmomanometer. The company was formerly known as Anhui Xunfei Medical Co., Ltd. and changed its name to Xunfei Healthcare Technology Co., Ltd. in February 2023.

The company was founded in 2016 and is headquartered in Hefei, the People's Republic of China.

Stock analysis

Xunfei Healthcare Tech Co Ltd (2506) currently trades at HK$65.25, while our estimate is HK$52.27, 20% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$39.21 (bear) to HK$65.34 (bull), the price of HK$65.25 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Xunfei Healthcare Tech Co Ltd reported revenue of 915M CNY in FY2025 versus 372M CNY in FY2021, a compound +25.2%/yr. Reported net income was −64.8M CNY in FY2025.

Key figures

Market cap HK$7.9B (≈ $1.0B) Small · P/S ratio 7.37 · Net margin −7.1% · Return on equity −3.5% · Return on assets (EBIT) −12.1% (5-year average) · Operating margin −15.5% · Revenue (TTM) 1.1B CNY · Revenue growth (YoY) +49.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).

What moves the price

The share trades about 39% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −20%, 2506 screens richer than that median.

Fair Value

Bear HK$39.21 Fair Value HK$52.27 Bull HK$65.34
Price HK$65.25 · Downside -19.9%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 14
How much profit the company makes from its sales and capital
Quality Growth 72
Are margins and returns getting better?
Cashflow 4
Do the profits arrive as real cash?
Financial strength 64
Debt, balance sheet and risk of trouble
Investment 14
Does it invest with discipline instead of growing at any price?
Low Volatility 20
How calm the share price moves, does not count
Price momentum 26
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 6
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+24.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−27.6% (2021) → −8.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

2506 screens overvalued: fair value 20% below the price. Compare with Veeva Systems Inc →

Compare Xunfei Healthcare Tech Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 39 · Below median
Fair Value upside −19.9% · Below median
Profitability
Return on assets −2.8% · Below median
Net margin (12 months) −4.7% · Below median
Operating margin (12 months) −15.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) 49.4% · Top 25%
Balance sheet
Debt / equity 0.15× · Above median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 7.46× · Priciest 25%
P/S (12 months) 6.30× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)7 · sector 15
FUTURE (revenue growth)100 · sector 44
PAST (return on equity)0 · sector 3
HEALTH (low debt)92 · sector 98
DIVIDEND (yield)0 · sector 43

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.77 $36.67 +12% vs 2506
Veeva Systems Inc VEEV $299.28 $329.21 +10% vs 2506
HealthEquity, Inc HQY $104.58 $115.04 +10% vs 2506
Waystar Holding WAY $28.11 $29.10 +4% vs 2506
Tempus AI, Inc TEM $64.76 $52.58 −19% vs 2506
HeartFlow, Inc HTFL $46.86 $30.50 −35% vs 2506
Hinge Health, Inc HNGE $121.29 $51.25 −58% vs 2506
Pro Medicus Limited PME A$201.65 A$82.80 −59% vs 2506
BrightSpring Health Services, Inc BTSG $71.37 $25.72 −64% vs 2506
XtalPi Holdings 2228 HK$5.53 HK$1.53 −72% vs 2506

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Xunfei Healthcare Tech Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Xunfei Healthcare Tech Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/2506

Frequently asked questions

Is Xunfei Healthcare Tech Co Ltd (2506) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is HK$52.27 versus a price of HK$65.25, about 20% lower (overvalued).
What is the fair value of 2506?
Our estimate for Xunfei Healthcare Tech Co Ltd is HK$52.27 (as of Nov 16, 2026), built from audited fundamentals. The current price: HK$65.25.
What is the quality score of 2506?
Xunfei Healthcare Tech Co Ltd has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xunfei Healthcare Tech Co Ltd (2506)?
Our calculated price target is the estimate of HK$52.27 (as of Nov 16, 2026). Cautious scenario HK$39.21, optimistic scenario HK$65.34. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Xunfei Healthcare Tech Co Ltd stock forecast for 2026?
Our estimate puts fair value at HK$52.27, about 20% lower versus a price of HK$65.25 (overvalued). Cautious scenario HK$39.21, optimistic scenario HK$65.34. The calculation is refreshed regularly with new filings.
What is the revenue of Xunfei Healthcare Tech Co Ltd (2506)?
Xunfei Healthcare Tech Co Ltd reported trailing-twelve-month revenue of about 1.1B CNY (latest available figure, as of Nov 16, 2026).
What is the intrinsic value of Xunfei Healthcare Tech Co Ltd (2506)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xunfei Healthcare Tech Co Ltd it is HK$52.27 per share (as of Nov 16, 2026), against a price of HK$65.25.
Is Xunfei Healthcare Tech Co Ltd stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 2506 trades above its calculated fair value: price HK$65.25, fair value HK$52.27, a gap of about −20% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 2506?
No. The price is what the market pays today (HK$65.25); the fair value is what the company's own numbers justify (HK$52.27). For Xunfei Healthcare Tech Co Ltd the two are HK$12.98 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xunfei Healthcare Tech Co Ltd worth?
The market values Xunfei Healthcare Tech Co Ltd at about HK$7.9B (market capitalisation, as of Nov 16, 2026). Per share that is HK$65.25; our models calculate a fair value of HK$52.27 per share.
What do the bullish and bearish scenarios say about 2506?
Our models span a range for Xunfei Healthcare Tech Co Ltd: cautious scenario HK$39.21, base HK$52.27, optimistic HK$65.34 per share (as of Nov 16, 2026, price HK$65.25). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Xunfei Healthcare Tech Co Ltd (2506)?
Balance-sheet figures for Xunfei Healthcare Tech Co Ltd (as of Nov 16, 2026): return on equity −3.5%, debt of 0.15 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 2506 from its 52-week high?
Xunfei Healthcare Tech Co Ltd trades at HK$65.25, about 39% below its 52-week high of HK$107.70 and 4% above the low of HK$62.75 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of HK$52.27 is for.
Which stocks are comparable to Xunfei Healthcare Tech Co Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xunfei Healthcare Tech Co Ltd stock attractive at the current price?
The data as of Nov 16, 2026: price HK$65.25, calculated fair value HK$52.27 (−20%), Quality Score 39/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Xunfei Healthcare Tech Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xunfei Healthcare Tech Co Ltd (2506)?
The closing price on Nov 16, 2026 was HK$65.25. Our estimate is HK$52.27, about 20% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xunfei Healthcare Tech Co Ltd right now?
Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Xunfei Healthcare Tech Co Ltd

How large is the market capitalisation of Xunfei Healthcare Tech Co Ltd (2506)?
The market capitalisation of Xunfei Healthcare Tech Co Ltd is HK$7.9B (≈ $1.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xunfei Healthcare Tech Co Ltd (2506)?
The price-to-sales ratio of Xunfei Healthcare Tech Co Ltd is 7.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Xunfei Healthcare Tech Co Ltd (2506)?
The net margin of Xunfei Healthcare Tech Co Ltd is −7.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Xunfei Healthcare Tech Co Ltd (2506)?
The return on equity (ROE) of Xunfei Healthcare Tech Co Ltd is −3.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xunfei Healthcare Tech Co Ltd (2506)?
On an EBIT basis the return on assets of Xunfei Healthcare Tech Co Ltd is −12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xunfei Healthcare Tech Co Ltd (2506)?
The operating margin of Xunfei Healthcare Tech Co Ltd is −15.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xunfei Healthcare Tech Co Ltd (2506)?
Revenue at Xunfei Healthcare Tech Co Ltd is growing 49.4% versus a year earlier (3y avg +24.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Xunfei Healthcare Tech Co Ltd (2506) generate?
The free cash flow of Xunfei Healthcare Tech Co Ltd is −156M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Xunfei Healthcare Tech Co Ltd (2506) carry?
The net debt of Xunfei Healthcare Tech Co Ltd is 156M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Xunfei Healthcare Tech Co Ltd in the live analysis

One click puts Xunfei Healthcare Tech Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.